Trials / Conditions / Bacterial Meningitis

Bacterial Meningitis

19 registered clinical trials studyying Bacterial Meningitis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis NCT07495150	yilong Wang	N/A
Not Yet Recruiting	Acute Treatment and Long-term Assessment of Adult Infectious Meningitis NCT07027475	Hospital Israelita Albert Einstein	—
Recruiting	Augmented Renal Clearance in Neurocritical Care NCT07410624	University of Alberta	—
Unknown	Early Diagnosis of Native and Device-associated Meningitis NCT05146570	Charite University, Berlin, Germany	N/A
Unknown	Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Aug NCT04771884	Shandong University	—
Completed	Confirmatory Study of BK1310 in Healthy Infants NCT03891758	Tanabe Pharma Corporation	Phase 3
Unknown	Neonatal Bacterial Meningitis Cohort NCT03499652	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	—
Completed	Meningitis With Cerebral Vasculitis in Children NCT03595761	University Hospital, Montpellier	—
Completed	Driving Reduced AIDS-associated Meningo-encephalitis Mortality NCT03226379	St George's, University of London	N/A
Unknown	Vitamin d Levels in Children With Bacterial Meningitis NCT02467309	Gang Liu	—
Recruiting	Central Nervous System Infections in Denmark NCT03418441	Aalborg University Hospital	—
Completed	DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Ja NCT02274285	Sanofi Pasteur, a Sanofi Company	Phase 3
Completed	Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DR NCT01589289	Institute of Tropical Medicine, Belgium	Phase 3
Completed	Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Ag NCT01547715	Novartis	Phase 3
Completed	Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Menin NCT01540838	University of Helsinki	Phase 4
Completed	Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care NCT01431326	Daniel Benjamin	—
Completed	Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Ta NCT01410474	Novartis	Phase 3
Terminated	IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis NCT00774631	Assistance Publique - Hôpitaux de Paris	Phase 4
Completed	Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis NCT00619203	Kamuzu University of Health Sciences	Phase 3